BiographyDr. Parker is an Assistant Professor in the Department of Epidemiology at Boston University School of Public Health. Her research interests include understanding the relationship between prenatal exposures and infant and childhood outcomes and the role of adverse pregnancy outcomes in maternal health. Dr. Parker is the Principal Investigator on a K-01 award from the National Heart, Lung, and Blood Institute (NHLBI) to investigate the role of adverse pregnancy outcomes in the development of coronary heart disease. She served as a consultant for the Centers for Disease Control and Prevention (CDC) Zika Response in 2016. She was awarded the Tyroler Lilienfeld Award (2014) by the Society of Epidemiologic Research for her dissertation work on preeclampsia. She received her Ph.D. from Boston University, where she was a trainee on the Boston University Reproductive, Perinatal, and Pediatric Training Grant, and her MSPH from Emory University. She has also previously worked at the Massachusetts Department of Public Health and the Slone Epidemiology Center at Boston University. Dr. Parker teaches Intermediate Epidemiology and Applications of Intermediate Epidemiology.
- Boston University School of Public Health, PhD
- Emory University, MS
- University of Miami, BS
- Published on 1/1/2019
Werler MM, Parker SE. Re: Herpesvirus Infection in Infants with Gastroschisis. Epidemiology. 2019 Jan; 30(1):e2. PMID: 30299407.
- Published on 9/1/2018
Werler MM, Guéry E, Waller DK, Parker SE. Gastroschisis and Cumulative Stressor Exposures. Epidemiology. 2018 09; 29(5):721-728. PMID: 29863532.
- Published on 8/1/2018
Parker SE, Van Bennekom C, Anderka M, Mitchell AA. Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects. Obstet Gynecol. 2018 Aug; 132(2):385-394. PMID: 29995744.
- Published on 4/16/2018
Parker SE, Keim SA. Medication and Misbehaving: What is the message? Paediatr Perinat Epidemiol. 2018 05; 32(3):256-257. PMID: 29663470.
- Published on 2/1/2018
Dukhovny S, Van Bennekom CM, Gagnon DR, Hernandez Diaz S, Parker SE, Anderka M, Werler MM, Mitchell AA. Metformin in the first trimester and risks for specific birth defects in the National Birth Defects Prevention Study. Birth Defects Res. 2018 04 17; 110(7):579-586. PMID: 29388358.
- Published on 11/2/2017
Werler MM, Parker SE. The Gastroschisis Puzzle: Where are We and What is Next? Paediatr Perinat Epidemiol. 2017 11; 31(6):560-562. PMID: 29096040.
- Published on 11/2/2017
Kerr SM, Parker SE, Mitchell AA, Tinker SC, Werler MM. Periconceptional maternal fever, folic acid intake, and the risk for neural tube defects. Ann Epidemiol. 2017 Dec; 27(12):777-782.e1. PMID: 29133009.
- Published on 7/7/2017
Harlow BL, Caron RE, Parker SE, Chatterjea D, Fox MP, Nguyen RHN. Recurrent Yeast Infections and Vulvodynia: Can We Believe Associations Based on Self-Reported Data? J Womens Health (Larchmt). 2017 Oct; 26(10):1069-1076. PMID: 28686502.
- Published on 7/1/2017
Peacock-Chambers E, Radesky JS, Parker SE, Zuckerman B, Lumeng JC, Silverstein M. Infant Regulatory Problems and Obesity in Early Childhood. Acad Pediatr. 2017 Jul; 17(5):523-528. PMID: 28669453.
- Published on 2/24/2017
Parker SE, Werler MM, Gissler M, Surcel HM. Maternal Antibodies to Chlamydia trachomatis and Risk of Gastroschisis. Birth Defects Res. 2017 May 01; 109(8):543-549. PMID: 28398639.
View 24 more publications:View full profile at BUMC